Xconomy |
Houston's Fannin Launches New Biotech, Exotect, to Treat Asthma
Xconomy Asthma treatments have typically focused on treating inflammation and constricted airways. Houston's Fannin Innovation Studio has launched a company that tackles the disease's third symptom: reducing overproduction of mucus. The company, called … |
View full post on asthma – Google News